Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2015 / Cilt: 55 - Sayı: 2

BARTH SYNDROME: NADİR BİR İNFANTİL KARDİYOMİYOPATİ

BARTH SYNDROME: A rare infantile cardiomyopathy

Pages
127–131
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

İn order to improve prognosis for these patients, a timely diagnosis is essential along with the immediate implementation of treatment for cardiomyopathy and infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Barth Syndrome, a rarely encountered recessive X-linked disease, mutates the Taffazzin gene located at Xq28 locus.
📊
Key Findings & Data:He was diagnosed with cardiomyopathy including dilatation, hypertrophy, and non-compaction of the left ventricle characterized by a decreased systolic function.
💡
Conclusion & Impact:İn order to improve prognosis for these patients, a timely diagnosis is essential along with the immediate implementation of treatment for cardiomyopathy and infection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Barth Syndrome, a rarely encountered recessive X-linked disease, mutates the Taffazzin gene located at Xq28 locus. Clinical findings of the syndrome include cardiomyopathy, proximal muscle myopathy, feeding difficulties, growth retardation, cyclic neutropenia, and suseptibility to infection. A case, diagnosed as Barth Syndrome, was presented in the study. The patient, a male, suffered from vomiting and feeding problems on the third day of life and succumbed to severe infection and neutropenia in the newborn period. He was diagnosed with cardiomyopathy including dilatation, hypertrophy, and non-compaction of the left ventricle characterized by a decreased systolic function. In the sixth month of life, he was admitted to the hospital with feeding problems, failure to thrive, septisemia, congestive heart failure, and a large thrombotic lesion on the right buttock. He died after a short time. The diagnosis of Barth Syndrome was made according to his clinical history and clinical echocardiographic findings. İn order to improve prognosis for these patients, a timely diagnosis is essential along with the immediate implementation of treatment for cardiomyopathy and infection.

Özet

Barth sendromu; Xq28 bölgesinde yer alan Taffazzin genindeki mutasyona bağlı olarak gelişen X bağlı resesif geçiş gösteren nadir sendromdur. Sendromun klinik bulguları; kardiyomiyopati, proksimal kas miyopatisi, beslenme bozuklukları, gelişme geriliği,siklik nötropeni ve enfeksiyonlara eğilimdir. Bu çalışmada; Barth Sendromu tanısı alan bir olgu sunulmaktadır. Yaşamının üçüncü gününde başlayan kusma, beslenme bozukluğu ile başvuran erkek olgu, yenidoğan döneminde ciddi enfeksiyonlar ve nötropeni tedavisi gördü.Bu evrede sol ventrikülde dilatasyon,hipertrofi ve nonkompakşın ve sistolik fonksiyonda azalma ile kardiyomiyopati tanısı aldı. Yaşamının altıncı ayında tekrar beslenme bozukluğu,gelişme geriliği,- sağ kalça üzerinde geniş trombotik lezyon, septisemi ve konjestif kalp yetmezliği ile başvurdu ve kısa sürede hasta kaybedildi. Olguya Barth Sendromu tanısı hastanın klinik ve ekokardiyografi bulgularına, hikayesine ve hastane kayıtlarına göre konuldu.Bu sendro ma sahip olgularda prognozun iyileştirilmesi zamanında teşhis edilmesi, kardiyomiyopati ve enfeksiyonların etkin ve hemen tedavisi esasdır.

🔖

Cite This Article

BÜYÜKKAYHAN, D., EROL, N. (2022). BARTH SYNDROME: NADİR BİR İNFANTİL KARDİYOMİYOPATİ. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 55 - Sayı: 2, 127–131. https://ajindex.com/articles/651369

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hong YM. Cardiomyopathies in children. Korean J Pediatr. 2013;56(2):52-59 2. JefferiesJ L. Barth Syndrome. American Journal of Medical Genetics Part C (Seminars in Medical Genetics). 2012;163C:198–205 3. Barth PG, Scholte HR, Berden JA, Van der KleiVan Moorsel JM, LuytHouwen IE, Van’tVeerKorthof ET, Van der Harten JJ, SobotkaPlojhar MA. An Xlinked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci. 1983;62:327–355 4. Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A. 2004;126:349–354 5. Clarke SLN, Bowron A, Gonzale IL, Groves SJ, Newbury-Echob R, Clayton N, Martin RP, Tsai-Goodman B, Garratt V, Ashworth M, Bowen VM, McCurdy KR, Damin MK, Spencer CT, Toth MJ, Kelley RI, Steward CG. Barth Syndrome. Orphanet Journal of Rare Diseases. 2013;8:23 6. Spencer CT, Bryant R M, Day J, Gonzales IL, Colan S, Thompson WR, Berthy J, Redfarn SP, Byrne BJ. Cardiac and Clinical Phenotype in Barth Syndrome. Pediatrics. 2006;118:e337 7. Rigaud C, Lebre AS, Touraine R, Beaupain B, Ottoleighi C, Chabli A, Ansquer H, Ozsahin H, Flippo S, Lonlay P, Borm B, Rivier F, Vaillant MC, Dramard MM, Goldenberg A, Viot G, Charron V, Rio M, Bonnet D, Donadieu J. Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet Journal of Rare Diseases. 2013;8:70 8. Schlbame M, Ren M. Barth Syndrome, a human disorder of cardiolipin metabolism. FEBS Letters. 2006;580:5450–5455 9. Yen TY, Hwu WL, Chien YH, Wu MH, Lin MT, Tsao LY, Hsieh WS, Lee NC. Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature rewiew. Eur J Pediatr. 2008;167:941– 944 10. Ferri L, Donati MA, Funghini S, Malvagia S, Catarzi S, Lugli L, Ragni L, Bertini E, Vaz F M, Cooper DN, Guerrini R, Morrone A. New clinical and molecular insight on Barth Syndrome. Orphanet Journal of Rare Diseases. 2013;8:27 11. Molina MS, Navarro GN, Molina FE, Martinez MJB, Escudero F, Espejo FR. Barth syndrome in adulthood: a clinical case scientic letters. Rev Esp Cardiol. 2013;66(1)64-73